UP!
| 2016-03-01 | Lower Price Target | Leerink Swann | Market Perform | $3.00 to $2.50 |
| 2015-12-27 | Upgrade | RBC Capital | Buy | |
| 2015-12-27 | Upgrade | Royal Bank Of Canada | Buy | |
| 2015-12-21 | Upgrade | RBC Capital | Sector Perform to Outperform | $4.00 to $5.00 |
| 2015-12-10 | Reiterated Rating | Leerink Swann | Mkt Perform | |
| 2015-12-09 | Reiterated Rating | Leerink Swann | Market Perform | $3.00 |
| 2015-03-05 | Boost Price Target | Leerink Swann | Outperform | $4.00 to $5.00 |
| 2014-05-12 | Reiterated | MLV & Co | Hold | $3 to $1.75 |
| 2014-05-12 | Lower Price Target | MLV & Co. | Hold | $3.00 to $1.75 |
| 2013-11-11 | Lower Price Target | RBC Capital | Sector Perform | $6.00 to $5.00 |
| 2013-09-18 | Downgrade | Citigroup Inc. | Buy to Neutral | $5.00 to $2.25 |
| 2013-05-24 | Reiterated | MLV & Co | Hold | $2.25 to $3 |
| 2013-01-14 | Downgrade | MLV & Co | Buy to Hold | $4 to $2.25 |
| 2012-10-02 | Downgrade | Needham | Buy to Hold | |
| 2012-09-12 | Initiated | Burrill Institutional Research | Mkt Outperform | $10 |
| 2012-07-30 | Initiated | Needham | Buy | |
| 2012-01-31 | Initiated | RBC Capital Mkts | Outperform | $11 |
| 2010-04-01 | Reiterated | Mehta Partners | Outperform | $5 to $9 |
| 2009-10-13 | Upgrade | UBS | Sell to Buy | |
| 2009-07-16 | Downgrade | UBS | Neutral to Sell | |
| 2009-06-10 | Reiterated | Lazard Capital Mkts | Buy | $5 to $7 |
| 2009-04-03 | Downgrade | UBS | Buy to Neutral | |
| 2008-12-12 | Initiated | UBS | Buy | |
| 2008-09-03 | Upgrade | Banc of America Sec | Neutral to Buy | $6 to $7 |
| 2008-08-13 | Reiterated | Cantor Fitzgerald | Buy | $9 to $7.50 |
| 2008-02-08 | Reiterated | Needham & Co | Buy | $14 to $12 |
| 2008-02-08 | Reiterated | Cantor Fitzgerald | Buy | $12 to $9 |
| 2016-03-01 | Lower Price Target | Leerink Swann | Market Perform | $3.00 to $2.50 |
| 2015-12-27 | Upgrade | RBC Capital | Buy | |
| 2015-12-27 | Upgrade | Royal Bank Of Canada | Buy | |
| 2015-12-21 | Upgrade | RBC Capital | Sector Perform to Outperform | $4.00 to $5.00 |
| 2015-12-10 | Reiterated Rating | Leerink Swann | Mkt Perform |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ARQL 11 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 2.03M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.66M |
| EverPoint Asset Management, LLC | 0.45M |
| TEACHERS ADVISORS INC | 0.22M |
| BlackRock Fund Advisors | 0.17M |
| COWEN GROUP, INC. | 37200 |
| BLACKROCK ADVISORS LLC | 14883 |
| OPPENHEIMER FUNDS INC | 13258 |
| RUSSELL FRANK CO/ | 12815 |
| BlackRock Investment Management, LLC | 10990 |
| LADENBURG THALMANN FINANCIAL SERVICES INC | 211 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| BVF PARTNERS L P/IL | 1.51% (947118) | ARQL / ARRY / CAPS / CCXI / CNCE / CTIC / INFI / LGND / NBIX / ONTY / PTN / RGDO / RGEN / RIGL / TRGT / XENE / |
| Pucci Paolo Chief Executive Officer | 0.64% (404194) | ARQL / DYAX / NLNK / WST / |
| LOBERG MICHAEL D | 0.26% (162514) | ARQL / |
| BARABE TIMOTHY C | 0.22% (136897) | AFFX / ARQL / OPXA / VEEV / |
| Lawrence Peter S President & COO | 0.12% (77743) | ARQL / |
| ZENNER PATRICK J | 0.12% (73770) | ARQL / EXAS / WST / |
| Kelley Susan L. | 0.08% (50000) | ARQL / CERU / IMDZ / |
| SCHWARTZ BRIAN Chief Scientific Officer | 0.07% (45738) | ARQL / |
| Weiskopf Robert J Vice President of Finance | 0.04% (23620) | ARQL / |
| Messenger William G | 0.02% (10000) | ARQL / |
UM